nitroglycerin has been researched along with fk 409 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (87.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Satoh, K; Taira, N; Yamada, H; Yoneyama, F | 1 |
| Hester, RK; Koibuchi, Y; Matsuo, M; Satake, N; Sato, N; Shibata, S | 1 |
| Furuichi, A; Isono, T; Kohsaka, M; Koibuchi, Y; Mori, J; Nishii, M; Ohtsuka, M; Sato, N; Yamamoto, T | 1 |
| Furuichi, A; Isono, T; Koibuchi, Y; Miura, S; Ohtsuka, M; Ozaki, R; Sato, N; Sawada, T; Yamamoto, T; Yamazaki, S | 1 |
| Isono, T; Kohsaka, M; Koibuchi, Y; Mori, J; Ohtsuka, M; Ozaki, R; Sakai, S; Sato, N; Yamamoto, T | 1 |
| Drieu la Rochelle, C; Grosset, A; Lainée, P; O'Connor, SE | 1 |
| Berkan, T; Erhan, Y; Kerry, Z; Ozdemir, N; Ozer, A; Reel, B; Sevin, G; Ustünes, L; Yasa, M; Yetik, G | 1 |
| Ascenzi, P; Colasanti, M; Gradoni, L; Mattu, M; Salvati, L; Scalone, A; Venturini, G | 1 |
8 other study(ies) available for nitroglycerin and fk 409
| Article | Year |
|---|---|
Comparison of the effects of the novel vasodilator FK409 with those of nitroglycerin in isolated coronary artery of the dog.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Coronary Vessels; Dogs; Female; Guanylate Cyclase; In Vitro Techniques; Male; Methylene Blue; Muscle Relaxation; Nitro Compounds; Nitroglycerin; Prostaglandin Endoperoxides, Synthetic; Purinones; Vasodilator Agents | 1991 |
Characteristics of the vasorelaxing action of (3E)-4-ethyl-2-hydroximino-5-nitro-3-hexamide FK409, a new vasodilator isolated from microbial sources, in isolated rabbit arteries.
Topics: Animals; Arteries; Caffeine; Calcium; Cyclic GMP; Hemoglobins; Histamine; In Vitro Techniques; Inositol Phosphates; Male; Methylene Blue; Nitro Compounds; Nitroglycerin; Norepinephrine; Purinones; Rabbits; Serotonin; Vasoconstriction; Vasodilator Agents | 1991 |
Vasorelaxant mechanism of the new vasodilator, FK409.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Arginine; Cyclic AMP; Cyclic GMP; Endothelium, Vascular; Guanylate Cyclase; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitro Compounds; Nitroglycerin; omega-N-Methylarginine; Oxyhemoglobins; Rabbits; Rats; Rats, Sprague-Dawley; Solubility; Vasodilator Agents | 1993 |
Tolerance to the vascular effect of a novel nitric oxide-donating vasodilator, FK409.
Topics: Animals; Antihypertensive Agents; Coronary Vessels; Cysteine; Dogs; Dose-Response Relationship, Drug; Drug Tolerance; Enzyme Activation; Female; Guanylate Cyclase; In Vitro Techniques; Injections, Intravenous; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitro Compounds; Nitroglycerin; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds; Vasodilator Agents | 1994 |
Effect of FK409, a novel nitric oxide donor, on acute experimental myocardial ischemia.
Topics: Animals; Coronary Circulation; Coronary Vessels; Dipyridamole; Disease Models, Animal; Dogs; Electric Stimulation; Electrocardiography; Female; In Vitro Techniques; Male; Methacholine Chloride; Myocardial Ischemia; Nitric Oxide; Nitro Compounds; Nitroglycerin; Rats; Vasodilation; Vasodilator Agents | 1993 |
Coronary and systemic hemodynamic effects of the putative nitric oxide donor, FK 409, in comparison with nitroglycerin in conscious and anesthetized dogs.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Cardiac Output; Coronary Circulation; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Female; Heart Rate; Injections, Intravenous; Male; Nitro Compounds; Nitroglycerin; Vascular Resistance; Vasodilation; Vasodilator Agents | 1995 |
Effects of treatment with FK409, a nitric oxide donor, on collar-induced intimal thickening and vascular reactivity.
Topics: Acetylcholine; Animals; Body Weight; Carotid Arteries; Dose-Response Relationship, Drug; Female; Male; Muscle, Smooth, Vascular; Nitric Oxide Donors; Nitro Compounds; Nitroglycerin; Phenylephrine; Rabbits; Serotonin; Vasoconstriction | 1999 |
NO donors inhibit Leishmania infantum cysteine proteinase activity.
Topics: Animals; Ascorbic Acid; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dithiothreitol; Glutathione; Kinetics; Leishmania infantum; Leupeptins; Molsidomine; Nitric Oxide; Nitric Oxide Donors; Nitro Compounds; Nitroglycerin; Nitroprusside; Nitroso Compounds; Penicillamine; Protozoan Proteins; S-Nitrosoglutathione | 2001 |